Category: Latest News
-
Fractyl Health shares rise 2.8% ahead of Virtual Commercial Strategy Day
Fractyl Health (NASDAQ:GUTS) shares rose 2.8% in pre-market trading ahead of the company’s Virtual Commercial Strategy Day, scheduled for 11:00 AM ET on Tuesday. Management is expected to provide details on the planned commercial strategy and market opportunity for Revita®, the company’s procedural therapy being developed for weight maintenance following discontinuation of GLP-1 treatments. The…
-
Kroger shares fall 1.2% after Citi issues short-term downside watch
Kroger (NYSE:KR) shares fell 1.2% in pre-market trading after Citi placed the supermarket group on a short-term downside Catalyst Watch ahead of its second-quarter 2026 earnings report. Citi expects Kroger to report second-quarter earnings per share of $1.05, in line with the current consensus estimate. However, the firm said it sees an increased likelihood that…
-
Duolingo shares rise 3.8% after Evercore ISI upgrade
Duolingo (NASDAQ:DUOL) shares rose 3.8% in pre-market trading after Evercore ISI analyst Mark Mahaney upgraded the stock to “Outperform” from “In Line” and raised the firm’s price target to $210. Evercore based its revised target on a valuation of 20 times estimated 2028 EBITDA. The firm also increased its earnings forecasts, with its 2027 and…
-
Robinhood Markets shares rise 2.4% after Morgan Stanley upgrade
Robinhood Markets (NASDAQ:HOOD) shares rose 2.4% in pre-market trading after Morgan Stanley upgraded the fintech brokerage to “Overweight” from “Equalweight” and increased its price target to $150 from $124. Morgan Stanley analysts cited evidence that Robinhood’s expanding range of financial products is increasing the value generated from its existing customer base, including higher assets and…
-
Cimpress shares edge lower as broader U.S. markets decline
Cimpress (NASDAQ:CMPR) shares fell 0.5% in pre-market trading to $88.64 as major U.S. equity indices moved lower ahead of the opening bell. No new company-specific announcement was identified in the supplied information as a direct catalyst for the move. Cimpress shares were trading within a range of $87.40 to $89.99 and remained below their 52-week…
-
Capricor Therapeutics shares rise 2.5% following August FDA update
Capricor Therapeutics (NASDAQ:CAPR) shares rose 2.5% in pre-market trading to $10.16, following regulatory developments in August concerning the company’s biologics license application for deramiocel. No new company-specific announcement was identified in the supplied information as a direct catalyst for Tuesday’s move. In mid-August, the U.S. Food and Drug Administration indicated that it was willing to…
-
WW International shares rise 3.1% in after-hours trading
WW International (NASDAQ:WW) shares rose 3.1% in after-hours trading to $17.21, extending their recovery from a 52-week low of $8.37 recorded in early May. No new company-specific announcement was identified in the supplied information as a direct catalyst for the after-hours increase. The latest move follows WW International’s second-quarter results in early August, when the…
-
Big Digital Energy shares rise 5.8% in after-hours trading
Big Digital Energy Inc (NASDAQ:BGDE) shares rose 5.8% in after-hours trading to $6.99, extending above the stock’s regular-session high of $6.81 as broader U.S. equity indices ended the session lower. No company press release or corporate announcement dated Tuesday was identified in the supplied information as a specific catalyst for the after-hours move. The increase…
-
Coincheck shares fall 4.3% amid broader market decline
Coincheck (NASDAQ:CNCK) shares fell 4.3% in pre-market trading to $2.02 as U.S. equity markets remained under pressure following renewed geopolitical tensions between the United States and Iran. No company-specific announcements, earnings releases or analyst actions linked to Coincheck’s pre-market move were identified in the supplied information. The Japanese cryptocurrency exchange operator’s shares remain below their…
-
Merck KGaA shares rise 1.7% after HSBC upgrades stock to Buy
Merck KGaA (NYSE:MRK) shares rose 1.7% to €141.30 after HSBC upgraded its rating on the Darmstadt-based science and technology group to “Buy” from “Hold”. HSBC also named Merck KGaA among its preferred companies in the life sciences tools sector, alongside Lonza, Danaher and Agilent. Analysts cited the company’s valuation, first-half 2026 growth and its performance…